Blood as a biological "drug": scientific, legal, and policy issues in the regulation of placental and umbilical cord stem cell transplantation.
D000329:Advertising; D035843:Biomedical Research; D001771:Blood Banks; D001782:Blood Donors; D032821:Commodification; D015507:Drugs, Investigational; D004467:Economics; D035082:Federal Government; D005312:Fetal Blood; D005820:Genetic Testing; D006076:Government; D033161:Government Regulation; D006801:Humans; D007221:Industry; D007231:Infant, Newborn; D007258:Informed Consent; D007603:Jurisprudence; D007878:Legislation as Topic; D009035:Mothers; D010067:Ownership; D033282:Parental Consent; D010290:Parents; D011057:Politics; D012106:Research; D012108:Research Personnel; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D012927:Social Control, Informal; D013234:Stem Cells; D020458:Third-Party Consent; D013997:Time Factors; D016378:Tissue Transplantation; D014481:United States; D014486:United States Food and Drug Administration
Health Care and Public Health; Human Tissues Safety Act 1996; Legal Approach